News

News

Trading Update - Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded

News

News

Hikma launches first prefilled syringe of Succinylcholine Chloride Injection, USP

News

News

Hikma announces the appointment of Deneen Vojta, M.D. as an independent Non-Executive Director, effective 1 November 2022

Find out more

Our Injectables manufacturing and supply in North America, Europe and MENA

Investor insight

Investor insight

Read here, the reasons to invest in Hikma

Investor insight

Investor insight

Listen to our audio webcast with Khalid Nabilsi, CFO & Riad Mishlawi, President, Injectables available until 14 February 2023

#OwnYourCareer @Hikma

#OwnYourCareer @Hikma

Meet Thomas Manhart, Customer Service Officer - Injectables, Germany site and discover why he loves working at Hikma!

#OwnYourCareer @Hikma

#OwnYourCareer @Hikma

Meet Selmoune Imane, Medical Representative, Algeria site and discover why she loves working at Hikma!

Find out more

Minimising our impact on the environment.

Careers

Careers

Join us in helping to put better health within reach for millions of people

Find out more

Find out more

Our 2021 Sustainability Report

Find out more

Find out more

Our 2021 Annual Report